CollPlant Biotechnologies (CLGN) Leases (2019 - 2025)

CollPlant Biotechnologies' Leases history spans 7 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Leases fell 18.89% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, down 18.89%, while the annual FY2025 figure was $2.4 million, 18.89% down from the prior year.
  • Leases reached $2.4 million in Q4 2025 per CLGN's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $3.1 million in Q4 2023 to a low of $2.4 million in Q4 2025.
  • Average Leases over 5 years is $2.8 million, with a median of $3.0 million recorded in 2021.
  • Peak YoY movement for Leases: rose 13.24% in 2023, then dropped 18.89% in 2025.
  • A 5-year view of Leases shows it stood at $3.0 million in 2021, then dropped by 8.2% to $2.7 million in 2022, then increased by 13.24% to $3.1 million in 2023, then fell by 2.57% to $3.0 million in 2024, then decreased by 18.89% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Leases are $2.4 million (Q4 2025), $3.0 million (Q4 2024), and $3.1 million (Q4 2023).